Short answer · Medically reviewed summary · Last updated: 2026-05-08
Factor V deficiency, also known as Owren’s disease or parahemophilia, was first clinically described in 1947 by Norwegian physician Paul Owren. It is a rare autosomal recessive bleeding disorder caused by a lack of the coagulation protein Factor V, which is essential for the blood clotting process. When was Factor V deficiency first discovered? In 1947, Dr.
What is the history of Factor V Deficiency?
History of Factor V Deficiency: when and how it was discovered, and the milestones in research since, medically reviewed.
Factor V deficiency, also known as Owren’s disease or parahemophilia, was first clinically described in 1947 by Norwegian physician Paul Owren. It is a rare autosomal recessive bleeding disorder caused by a lack of the coagulation protein Factor V, which is essential for the blood clotting process.
When was Factor V deficiency first discovered?
In 1947, Dr. Paul Owren identified a patient with a unique bleeding disorder that did not fit the profiles of Hemophilia A or B. He discovered that the patient lacked a previously unknown clotting factor, which he named "Factor V." Before this, Factor V deficiency was often misdiagnosed as other forms of hemophilia, leading to ineffective treatments for patients who were struggling with unexplained bruising or hemorrhaging.
How has our understanding of Factor V deficiency evolved?
Initially, researchers believed Factor V deficiency was a simple protein-level issue. However, the advent of molecular genetics in the 1990s revealed that it is caused by mutations in the F5 gene on chromosome 1. This scientific leap allowed clinicians to distinguish between the rare bleeding disorder and the more common "Factor V Leiden," a mutation that actually increases the risk of clotting—a major historical misconception that caused confusion in early literature.
What are the major milestones in managing Factor V deficiency?
The management of Factor V deficiency has shifted from supportive care to precision medicine. Key historical and clinical milestones include:
- 1947: The formal identification and characterization of the deficiency by Dr. Owren.
- 1960s-70s: The development of fresh frozen plasma (FFP) transfusions as the primary method to replace missing clotting factors.
- 1990s: The mapping of the F5 gene, enabling accurate genetic counseling and prenatal testing.
- Modern Era: The use of recombinant technology and antifibrinolytic agents to manage bleeding episodes with fewer risks of transfusion-transmitted infections.
How has patient advocacy changed the landscape?
With only 3 individuals currently sharing their journey on DiseaseMaps.org, the community remains small but vital. Early patients with Factor V deficiency often felt isolated due to the rarity of the condition. Today, global patient organizations and digital platforms have allowed those with Factor V deficiency to connect, share symptom management strategies, and drive research funding for rare blood disorders.
Next steps
- Consult a hematologist specializing in coagulation disorders to review your specific F5 gene mutation.
- Join a patient advocacy group to connect with others living with Factor V deficiency.
- Maintain a detailed medical record of your bleeding history to assist in future emergency planning.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Factor V deficiency
- Orphanet: Parahemophilia (Factor V deficiency)
- OMIM (Online Mendelian Inheritance in Man): Factor V deficiency entry #227400
- National Hemophilia Foundation: Rare Bleeding Disorders resource center
